173 related articles for article (PubMed ID: 27686798)
1. Long Non-Coding RNA: An Emerging Paradigm of Pancreatic Cancer.
Han T; Hu H; Zhuo M; Wang L; Cui JJ; Jiao F; Wang LW
Curr Mol Med; 2016; 16(8):702-709. PubMed ID: 27686798
[TBL] [Abstract][Full Text] [Related]
2. The regulatory roles of long noncoding RNAs in the biological behavior of pancreatic cancer.
Li Y; Yang X; Kang X; Liu S
Saudi J Gastroenterol; 2019; 25(3):145-151. PubMed ID: 30720003
[TBL] [Abstract][Full Text] [Related]
3. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
4. LncRNAs in pancreatic cancer.
Huang X; Zhi X; Gao Y; Ta N; Jiang H; Zheng J
Oncotarget; 2016 Aug; 7(35):57379-57390. PubMed ID: 27429196
[TBL] [Abstract][Full Text] [Related]
5. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
6. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
[TBL] [Abstract][Full Text] [Related]
8. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
9. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer.
Peng W; Jiang A
Biomed Pharmacother; 2016 Oct; 83():712-717. PubMed ID: 27470572
[TBL] [Abstract][Full Text] [Related]
11. Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review.
Al-Noshokaty TM; Mansour A; Abdelhamid R; Abdellatif N; Alaaeldien A; Reda T; Abdelmaksoud NM; Doghish AS; Abulsoud AI; Elshaer SS
Pathol Res Pract; 2023 May; 245():154438. PubMed ID: 37043965
[TBL] [Abstract][Full Text] [Related]
12. Novel perspectives of long non-coding RNAs in esophageal carcinoma.
Lin CY; Xu HM
Carcinogenesis; 2015 Nov; 36(11):1255-62. PubMed ID: 26392258
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs: novel insights into gastric cancer.
Fang XY; Pan HF; Leng RX; Ye DQ
Cancer Lett; 2015 Jan; 356(2 Pt B):357-66. PubMed ID: 25444905
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer.
Chen P; Wan D; Zheng D; Zheng Q; Wu F; Zhi Q
Biomed Pharmacother; 2016 Oct; 83():1220-1226. PubMed ID: 27562722
[TBL] [Abstract][Full Text] [Related]
17. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
18. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway.
Li X; Deng SJ; Zhu S; Jin Y; Cui SP; Chen JY; Xiang C; Li QY; He C; Zhao SF; Chen HY; Niu Y; Liu Y; Deng SC; Wang CY; Zhao G
Oncotarget; 2016 Feb; 7(5):6000-14. PubMed ID: 26755660
[TBL] [Abstract][Full Text] [Related]
20. Tissue-Specific Down-Regulation of the Long Non-Coding RNAs PCAT18 and LINC01133 in Gastric Cancer Development.
Foroughi K; Amini M; Atashi A; Mahmoodzadeh H; Hamann U; Manoochehri M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
